Zobrazeno 1 - 10
of 305
pro vyhledávání: '"Mingorance‐Le Meur, A"'
Publikováno v:
In Epilepsy & Behavior March 2015 44:104-109
Publikováno v:
PLoS ONE, Vol 9, Iss 1, p e84755 (2014)
Research in the epilepsy field is moving from a primary focus on controlling seizures to addressing disease pathophysiology. This requires the adoption of resource- and time-consuming animal models of chronic epilepsy which are no longer able to sust
Externí odkaz:
https://doaj.org/article/ce0fbc5a4f2245f09d23a748309d9c28
Autor:
Ana Mingorance-Le Meur
Publikováno v:
Communicative & Integrative Biology, Vol 2, Iss 4, Pp 318-320 (2009)
The mature central nervous system has a very limited capacity to repair itself after injury or disease, often leading to lifelong disabilities. Two key questions in neurobiology are why the brain has such limited plasticity, and how we could enhance
Externí odkaz:
https://doaj.org/article/e9a4dfe04799469db4b2019661ece0c2
Autor:
Pacico, Nathalie1, Mingorance-Le Meur, Ana1 ana.mingorance@ucb.com
Publikováno v:
PLoS ONE. Jan2014, Vol. 9 Issue 1, p1-9. 9p.
Publikováno v:
PLoS ONE, Vol 4, Iss 2, p e4334 (2009)
The rat adrenal pheochromocytoma PC12 cell line is one of the traditional models for the study of neurite outgrowth and growth cone behavior. To clarify to what extent PC12 neurite terminals can be compared to neuronal growth cones, we have analyzed
Externí odkaz:
https://doaj.org/article/d8994a304f0141b991721ee8880f9bcf
Autor:
Mingorance‐Le Meur, A1, Ghisdal, P1, Mullier, B1, De Ron, P1, Downey, P1, Van Der Perren, C1, Declercq, V1, Cornelis, S1, Famelart, M1, Van Asperen, J1, Jnoff, E1, Courade, J P1
Publikováno v:
British Journal of Pharmacology. Nov2013, Vol. 170 Issue 5, p1053-1063. 11p.
Autor:
Mingorance-Le Meur, Ana1 alemeur@interchange.ubc.ca, Mohebiany, Alma N.1, O'Connor, Timothy P.1
Publikováno v:
PLoS ONE. 2009, Vol. 4 Issue 2, p1-8. 8p. 5 Color Photographs, 1 Diagram, 1 Graph.
Publikováno v:
Epilepsy & Behavior. 44:104-109
Dravet syndrome is a rare form of epilepsy largely refractory to current antiepileptic medications. The only precedents of randomized placebo-controlled trials in Dravet syndrome are the two small trials that led to the approval of stiripentol. With
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acdc5501a3f3fc23627b988e2146caa4
Autor:
J. van Asperen, C Van Der Perren, V Declercq, S Cornelis, Michel Famelart, P De Ron, B Mullier, Eric Jnoff, Jean-Philippe Courade, P Ghisdal, Patrick Downey, A Mingorance-Le Meur
Publikováno v:
British Journal of Pharmacology. 170:1053-1063
Background and Purpose Available medications for chronic pain provide only partial relief and often cause unacceptable side effects. There is therefore a need for novel molecular targets to develop new therapeutics with improved efficacy and tolerabi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b19275f085ac602eb71efe2fc2d8acb6
https://doi.org/10.1111/bph.12343
https://doi.org/10.1111/bph.12343
Autor:
Mishra, Nigam M.1 (AUTHOR), Spitznagel, Brittany D.2 (AUTHOR), Du, Yu2,3 (AUTHOR), Mohamed, Yasmeen K.1 (AUTHOR), Qin, Ying1,4 (AUTHOR), Weaver, C. David2,3 (AUTHOR), Emmitte, Kyle A.1 (AUTHOR) kyle.emmitte@unthsc.edu
Publikováno v:
Molecules. Dec2024, Vol. 29 Issue 23, p5494. 19p.